Literature DB >> 19574297

The role of AUF1 in thyroid carcinoma progression.

Bogusz Trojanowicz1, Lars Brodauf, Carsten Sekulla, Kerstin Lorenz, Rainer Finke, Henning Dralle, Cuong Hoang-Vu.   

Abstract

AUF1/heterogeneous nuclear ribonucleoprotein D is an adenylate-uridylate-rich elements (AREs) -binding protein, which regulates the mRNA stability of many genes related to growth regulation, such as proto-oncogenes, growth factors, cytokines, and cell cycle-regulatory genes. Several studies demonstrated AUF1 involvement in the processes of apoptosis, tumorigenesis, and development by its interactions with ARE-bearing mRNAs. We report here that AUF1 may be involved in thyroid carcinoma progression. Investigations on thyroid tissues revealed that cytoplasmic expression of AUF1 in malignant tissues was increased when compared with benign thyroid tissues. In thyroid carcinoma cell lines, AUF1 was mostly detectable in the nucleus; however, in dividing cells, its increased production was also observed in the cytoplasm. We found AUF1 in complexes with ARE-bearing mRNAs, previously described to be crucial for proliferation and cell cycle of thyroid carcinoma. Total or exon-selective knockdown of AUF1 led to growth inhibition accompanied by induction of cell cycle inhibitors and decreased levels of cell cycle promoters. Our data demonstrate the existence of a complex network between AUF1 and mRNAs encoding proteins related to cell proliferation. AUF1 may control the balance between stabilizing and destabilizing effects, both of which are exerted on cell cycle machinery in thyroid carcinoma. Although we cannot exclude participation of other factors, thyroid carcinoma may recruit cytoplasmic AUF1 to disturb the stability of mRNAs encoding cyclin-dependent kinase inhibitors, leading to uncontrolled growth and progression of tumor cells. Thus, AUF1 may be considered as a new, additional marker for thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19574297     DOI: 10.1677/ERC-08-0234

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  12 in total

1.  MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic mesenchymal characteristics through the RNA-binding protein AUF1 targeting the transcription factor ZEB1 and the protein kinase AKT.

Authors:  Huda H Al-Khalaf; Abdelilah Aboussekhra
Journal:  J Biol Chem       Date:  2014-09-26       Impact factor: 5.157

2.  The cytokine IL-6 reactivates breast stromal fibroblasts through transcription factor STAT3-dependent up-regulation of the RNA-binding protein AUF1.

Authors:  Siti-Fauziah Hendrayani; Huda H Al-Khalaf; Abdelilah Aboussekhra
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

Review 3.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

Review 4.  Modulation of neoplastic gene regulatory pathways by the RNA-binding factor AUF1.

Authors:  Beth E Zucconi; Gerald M Wilson
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01

5.  AUF1 p42 isoform selectively controls both steady-state and PGE2-induced FGF9 mRNA decay.

Authors:  Tsung-Ming Chen; Chien-Hui Hsu; Shaw-Jenq Tsai; H Sunny Sun
Journal:  Nucleic Acids Res       Date:  2010-08-16       Impact factor: 16.971

6.  AUF1 and HuR: possible implications of mRNA stability in thyroid function and disorders.

Authors:  Bogusz Trojanowicz; Henning Dralle; Cuong Hoang-Vu
Journal:  Thyroid Res       Date:  2011-08-03

7.  Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.

Authors:  Manish Kumar; Ajay Matta; Olena Masui; Gunjan Srivastava; Jatinder Kaur; Alok Thakar; Nootan Kumar Shukla; Ajoy RoyChoudhury; Meherchand Sharma; Paul G Walfish; K W Michael Siu; Shyam Singh Chauhan; Ranju Ralhan
Journal:  J Transl Med       Date:  2015-08-30       Impact factor: 5.531

8.  AUF1 Promotes Proliferation and Invasion of Thyroid Cancer via Downregulation of ZBTB2 and Subsequent TRIM58.

Authors:  Xin Du; Jia-Mei Wang; Da-Lin Zhang; Tong Wu; Xiao-Yan Zeng; Jing-Yi Jiang; Zhen-Xian Du
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

9.  Unraveling Molecular Differences of Gastric Cancer by Label-Free Quantitative Proteomics Analysis.

Authors:  Peng Dai; Qin Wang; Weihua Wang; Ruirui Jing; Wei Wang; Fengqin Wang; Kazem M Azadzoi; Jing-Hua Yang; Zhen Yan
Journal:  Int J Mol Sci       Date:  2016-01-21       Impact factor: 5.923

10.  Induction of epithelial-mesenchymal transition (EMT) by Beclin 1 knockdown via posttranscriptional upregulation of ZEB1 in thyroid cancer cells.

Authors:  Si Li; Hai-Yan Zhang; Zhen-Xian Du; Chao Li; Ming-Xin An; Zhi-Hong Zong; Bao-Qin Liu; Hua-Qin Wang
Journal:  Oncotarget       Date:  2016-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.